Stephen T. Chen - 27 Jun 2022 Form 4 Insider Report for Ainos, Inc. (AIMD)

Role
FORMER DIRECTOR & OFFICER
Signature
/s/ John Junyong Lee, POA for Stephen T. Chen
Issuer symbol
AIMD
Transactions as of
27 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 19:21:22 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AIMD COMMON STOCK 1,938,227 27 Jun 2022 Direct
holding AIMD COMMON STOCK 594,915 27 Jun 2022 STC International F1
holding AIMD COMMON STOCK 39,473 27 Jun 2022 ACTS Biosciences F2
holding AIMD COMMON STOCK 740,243 27 Jun 2022 Spouse F3
holding AIMD COMMON STOCK 4,527,967 27 Jun 2022 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AIMD Convertible Promissory Note 0 27 Jun 2022 Common Stock 670,741 $0.1700 Direct F5
holding AIMD Convertible Promissory Note 0 27 Jun 2022 Common Stock 1,381,578 $0.1900 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Stephen T. Chen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 STC International, Inc. - Stephen Chen is Chairman, Board Member and Major Stockholder
F2 ACTS Biosciences, Inc. - Stephen Chen is Chairman and Major Stockholder
F3 Spouse - Virginia M. Chen IRA
F4 Trust - Stephen T Chen Virginia M Chen TTEES Stephen T Virginia M Chen Living Trust DTD 04/12/2018
F5 On Demand